JP2011511081A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511081A5
JP2011511081A5 JP2010545948A JP2010545948A JP2011511081A5 JP 2011511081 A5 JP2011511081 A5 JP 2011511081A5 JP 2010545948 A JP2010545948 A JP 2010545948A JP 2010545948 A JP2010545948 A JP 2010545948A JP 2011511081 A5 JP2011511081 A5 JP 2011511081A5
Authority
JP
Japan
Prior art keywords
compound
represented
compound according
alkyl
following formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010545948A
Other languages
English (en)
Japanese (ja)
Other versions
JP5566912B2 (ja
JP2011511081A (ja
Filing date
Publication date
Priority claimed from US12/363,996 external-priority patent/US8455547B2/en
Application filed filed Critical
Publication of JP2011511081A publication Critical patent/JP2011511081A/ja
Publication of JP2011511081A5 publication Critical patent/JP2011511081A5/ja
Application granted granted Critical
Publication of JP5566912B2 publication Critical patent/JP5566912B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010545948A 2008-02-05 2009-02-03 プロスタグランジン活性を有する置換シクロペンタン類 Expired - Fee Related JP5566912B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2617908P 2008-02-05 2008-02-05
US61/026,179 2008-02-05
US12/363,996 US8455547B2 (en) 2008-02-05 2009-02-02 Substituted cyclopentanes having prostaglandin activity
US12/363,996 2009-02-02
PCT/US2009/032943 WO2009100057A1 (en) 2008-02-05 2009-02-03 Substituted cyclopentanes having prostaglandin activity

Publications (3)

Publication Number Publication Date
JP2011511081A JP2011511081A (ja) 2011-04-07
JP2011511081A5 true JP2011511081A5 (https=) 2012-03-22
JP5566912B2 JP5566912B2 (ja) 2014-08-06

Family

ID=40932327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010545948A Expired - Fee Related JP5566912B2 (ja) 2008-02-05 2009-02-03 プロスタグランジン活性を有する置換シクロペンタン類

Country Status (12)

Country Link
US (1) US8455547B2 (https=)
EP (2) EP2245005A1 (https=)
JP (1) JP5566912B2 (https=)
KR (1) KR20100119787A (https=)
CN (1) CN101959854A (https=)
AU (1) AU2009212570B2 (https=)
BR (1) BRPI0907913A2 (https=)
CA (1) CA2713958A1 (https=)
IL (1) IL207354A0 (https=)
MX (1) MX2010008589A (https=)
RU (1) RU2505530C2 (https=)
WO (1) WO2009100057A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2418592C1 (ru) * 2010-04-19 2011-05-20 Геннадий Васильевич Порядин Способ лечения артериальной гипертонии
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388443A (en) * 1971-06-11 1975-03-26 Searle & Co Selective reduction of 9,15-dioxoprostanoic acids
JPS55133354A (en) * 1979-04-02 1980-10-17 Upjohn Co Prostaglandin derivatives
US4259516A (en) * 1979-04-02 1981-03-31 The Upjohn Company 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds
US4675182A (en) 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
DE3304864A1 (de) * 1983-02-12 1984-08-16 Bayer Ag, 5090 Leverkusen Adsorbate von prostaglandinen
ATE266397T1 (de) 1997-02-04 2004-05-15 Murray A Johnstone Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
SE9702681D0 (sv) * 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
AU2004211936B2 (en) * 2003-02-11 2008-09-11 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
TWI495471B (zh) 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
PL1759702T3 (pl) 2004-05-26 2009-06-30 Bayardo Arturo Jimenez Sposób wytwarzania roztworu latanoprostu do oczu oraz roztwór otrzymany tym sposobem
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
GB0524103D0 (en) 2005-11-26 2006-01-04 Medical Res Council Healing
US7476755B2 (en) * 2006-05-04 2009-01-13 Allergan, Inc. Therapeutic compounds
EP2037967B1 (en) 2006-06-16 2016-12-07 The Trustees Of The University Of Pennsylvania Prostaglandin d2 receptor antagonists for treating androgenetic alopecia

Similar Documents

Publication Publication Date Title
JP2007302689A5 (https=)
JP2011518833A5 (https=)
JP2015521167A5 (https=)
JP2009114217A5 (https=)
JP2018518537A5 (https=)
JP2009535462A5 (https=)
JP2009539828A5 (https=)
JP2011516477A5 (https=)
JP2009543795A5 (https=)
JP2013519645A5 (https=)
AR047972A1 (es) Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas.
JP2013512277A5 (https=)
JP2009507909A5 (https=)
JP2011527332A5 (https=)
JP2018537535A5 (https=)
JP2015508092A5 (https=)
JP2015502974A5 (https=)
JP2010510232A5 (https=)
EP3404029A3 (en) Pyrimido-pyridazinone compounds and methods and use thereof
JP2012512863A5 (https=)
JP2010521516A5 (https=)
JP2008513510A5 (https=)
JP2011515406A5 (https=)
RU2007118691A (ru) Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника
JP2011511081A5 (https=)